GlassScriptPhysician profile
Mayank Bhayana
NPI 1477992899
$871.35
in general payments reported to CMS, 2019-2025
19 companies · $23.22 in 2025
The $23.22 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $41.31 · 2021: $91.62 · 2022: $225 · 2023: $175 · 2024: $77.96 · 2025: $23.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $119.97 | 2019-2024 | Xarelto |
| Ferring Pharmaceuticals INC. | $88.33 | 2022-2023 | Rebyota |
| Astrazeneca Pharmaceuticals LP | $87.81 | 2019-2023 | Farxiga |
| Pfizer INC. | $87.70 | 2022-2025 | |
| Mylan Specialty L.P. | $65.54 | 2019-2022 | |
| Melinta Therapeutics, LLC | $59.47 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.55 | 2021-2022 | |
| Csl Behring | $50.13 | 2019-2021 | |
| Vifor Pharma, INC. | $42.69 | 2019 | |
| Gilead Sciences, INC. | $38.95 | 2023-2024 | Veklury |
| Abbvie INC. | $32.46 | 2022-2023 | Teflaro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.31 | 2019-2024 | Lifevest |
| Smith+Nephew, INC. | $18.54 | 2022 | |
| Cmp Pharma, INC. | $17.99 | 2020 | |
| Novo Nordisk INC | $17.59 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 414 LLC | $15.88 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $15.23 | 2022 | |
| Phadia US INC. | $13.66 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayank Bhayana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.